A detailed history of C M Bidwell & Associates LTD transactions in Innoviva, Inc. stock. As of the latest transaction made, C M Bidwell & Associates LTD holds 225 shares of INVA stock, worth $4,002. This represents 0.0% of its overall portfolio holdings.

Number of Shares
225
Previous 225 -0.0%
Holding current value
$4,002
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$14.56 - $16.78 $129,860 - $149,660
-8,919 Reduced 97.54%
225 $3,000
Q2 2023

Aug 11, 2023

BUY
$11.39 - $13.72 $56,084 - $67,557
4,924 Added 116.68%
9,144 $116,000
Q1 2023

May 11, 2023

SELL
$10.73 - $13.6 $7,618 - $9,656
-710 Reduced 14.4%
4,220 $47,000
Q4 2022

Feb 10, 2023

BUY
$11.8 - $13.78 $58,174 - $67,935
4,930 New
4,930 $65,000
Q3 2020

Nov 13, 2020

SELL
$10.33 - $14.49 $21,228 - $29,776
-2,055 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$11.49 - $15.26 $23,611 - $31,359
2,055 New
2,055 $29,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track C M Bidwell & Associates LTD Portfolio

Follow C M Bidwell & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on C M Bidwell & Associates LTD with notifications on news.